Immunology Treatment Advancements Highlighted a...

By João L. Carapinha

June 1, 2026

Immunology Treatment Advancements are accelerating as Novartis prepares to unveil data from 31 abstracts at the European Alliance of Associations for Rheumatology (EULAR) Congress, June 3-6, 2026 in London. The presentations focus on high-burden a...